India, June 10 -- The Government of India issued the following news release:
Translational Health Science and Technology Institute (THSTI) hosted a symposium on the Discovery and Development of Monoclonal Antibody Therapeutics today at its campus. This event brought together leading experts from the pharmaceutical industry, start-ups, CRDMOs, various funding organizations (such as BIRAC, Wadhwani Foundation), and academic organizations for scientific knowledge exchange and to explore innovative models for advancing monoclonal antibody (mAb) therapies in India.
The symposium underscored India's burgeoning biopharmaceutical sector and the immense potential for indigenous innovation in this critical area. A key highlight of the discussions w...